Skip to main content

GENOIL INC

corporate_fare Company Profile

GENOIL INC

GNOLF·OTC·Energy & Transportation·CIK 0001261002

Genoil is a Canadian company focused on developing technologies for the oil and gas industry, with a current goal to commercialize these technologies internationally. The Corporation holds rights to several patented and proprietary technologies, from which a number of products are under development. None of its technologies have been commercialized to date. Genoil formed a joint venture called "Genoil Emirates" with SBK Commercial Business Group in the United Arab Emirates. This new corporation aims to develop projects in the U.A.E. utilizing all of Genoil's technologies, including desulfurization, oil upgrading and recycling, water purification port technologies, well testing, and sand cleaning. The United Arab Emirates currently possesses the seventh largest oil reserves globally and is seeking to increase production. Genoil Emirates has its head office in Riyadh, 11321 Kingdom of Saudi Arabia, at Building B, Near Gulf Commercial Complex Olaya, P.O. Box: 230032. It also maintains a branch location at Khober DAMAM, Block 7 Office 32 Khober. Genoil's primary focus has been on developing and applying its proprietary heavy oil upgrading technology, known as the Genoil Hydroconversion Upgrader (GHU). The GHU technology is designed to transform sour (high sulfur), heavy hydrocarbon feedstocks into lighter oil, yielding higher quality distillates suitable for conventional refining. The GHU process employs a hydrogen enrichment method based on catalytic hydrogenation and flash separation.

GENOIL INC (OTC:GNOLF) is a publicly traded company in the Energy & Transportation sector. Wiseek has independently scored 2 items for GNOLF at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-03, rated 8/10. Across its 2 most recent items scored 7 or higher, the top rating is 10/10, with 2 rated 8 or above. Recent SEC coverage for GNOLF spans 6-K, 20-F.

Recent high-impact activity:

  • Genoil Q1 2026: $1.64M Loss, $12 Cash, Going-Concern Doubt Reaffirmed
  • Genoil Inc. Reports Substantial Doubt About Going Concern, Near-Zero Cash, and Material Internal Control Weaknesses

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$0
Net Income
-$640.5K
Diluted EPS
$0.00
Op. Cash Flow
-$516.3K
Gross Profit
$0
Operating Income
-$626.09K
Cash & Equivalents
$12
Total Debt
$220.14K
Debt / Equity
-0.43×
Shares Outstanding
2.02B sh
Source: 20-F · filed 2026-05-13 · accession 0001654954-26-004801

Insider Transactions

GNOLF files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

$0.0197
52-week range · as of 2026-11-03 $0.000001 – $0.03
Market cap
$40.1M
Volume
2.7K (0.0× avg)
3-mo avg 148.4K
Live data · 2026-11-20 21:09 UTC · After hours

show_chartPrice Chart

Loading chart...

feed GNOLF - Latest Insights

GNOLF
Nov 03, 2026, 9:39 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.0244
Real-time Price: $0.0197 info
Change: -$0.0047 (-19%) info
Market Cap: $40.104M info
GNOLF
May 13, 2026, 11:37 AM EDT
Filing Type: 20-F
Importance Score:
10
Price at Filing: $0.000001
Real-time Price: $0.0197 info
Change: N/A info
Market Cap: $40.104M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets